关注
Selvaraman Nagamani
Selvaraman Nagamani
Scientist, Advanced Computation and Data Sciences Division, CSIR-North East Institute of Science and Technology
在 neist.res.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors
KD Singh, M Karthikeyan, P Kirubakaran, S Nagamani
Journal of Molecular Graphics and Modelling 30, 186-197, 2011
562011
Effect of plant growth regulators on sex expression, fruit setting, seed yield and quality in the parental lines for hybrid seed production in bitter gourd (Momordica charantia)
S Nagamani, S Basu, S Singh, SK Lal, TK Behera, SK Chakrabarty, ...
Indian Journal of Agricultural Sciences 85 (9), 1185-91, 2015
362015
High throughput virtual screening and E-pharmacophore filtering in the discovery of new BACE-1 inhibitors
K Muthusamy, KD Singh, S Chinnasamy, S Nagamani, G Krishnasamy, ...
Interdisciplinary Sciences: Computational Life Sciences 5, 119-126, 2013
302013
Ligand-based pharmacophore modeling; atom-based 3D-QSAR analysis and molecular docking studies of phosphoinositide-dependent kinase-1 inhibitors
P Kirubakaran, K Muthusamy, KHD Singh, S Nagamani
Indian Journal of Pharmaceutical Sciences 74 (2), 141, 2012
292012
Identification of potent inhibitors against snake venom metalloproteinase (SVMP) using molecular docking and molecular dynamics studies
S Chinnasamy, S Chinnasamy, S Nagamani, K Muthusamy
Journal of Biomolecular Structure and Dynamics 33 (7), 1516-1527, 2015
282015
E-Pharmacophore mapping and docking studies on Vitamin D receptor (VDR)
S Nagamani, C Kesavan, K Muthusamy
Bioinformation 8 (15), 705, 2012
222012
Zn 2+ ion of the snake venom metalloproteinase (SVMP) plays a critical role in ligand binding: A molecular dynamics simulation study
S Chinnasamy, S Nagamani, K Muthusamy
RSC advances 5 (86), 70566-70576, 2015
212015
Molecular descriptor analysis of approved drugs using unsupervised learning for drug repurposing
SS Madugula, L John, S Nagamani, AS Gaur, VV Poroikov, GN Sastry
Computers in Biology and Medicine 138, 104856, 2021
202021
Mycobacterium tuberculosis Cell Wall Permeability Model Generation Using Chemoinformatics and Machine Learning Approaches
S Nagamani, GN Sastry
ACS omega 6 (27), 17472-17482, 2021
192021
In silico structural and functional analysis of the human TOPK protein by structure modeling and molecular dynamics studies
P Kirubakaran, M Karthikeyan, KD Singh, S Nagamani, K Premkumar
Journal of molecular modeling 19, 407-419, 2013
192013
Molecular property diagnostic suite for diabetes mellitus (MPDSDM): an integrated web portal for drug discovery and drug repurposing
AS Gaur, S Nagamani, K Tanneeru, D Druzhilovskiy, A Rudik, V Poroikov, ...
Journal of Biomedical Informatics 85, 114-125, 2018
182018
In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme
P Kirubakaran, R Kothapalli, KD Singh, S Nagamani, S Arjunan, ...
Bioinformation 6 (3), 100, 2011
182011
Homology modeling, molecular dynamics, and molecular docking studies of Trichomonas vaginalis carbamate kinase
P Kirubakaran, K Muthusamy, K Dhanachandra Singh, S Nagamani
Medicinal Chemistry Research 21, 2105-2116, 2012
162012
Applying polypharmacology approach for drug repurposing for SARS-CoV2
E Jamir, H Sarma, L Priyadarsinee, S Nagamani, K Kiewhuo, AS Gaur, ...
Journal of Chemical Sciences 134 (2), 57, 2022
152022
A theoretical insight to understand the molecular mechanism of dual target ligand CTA-018 in the chronic kidney disease pathogenesis
N Selvaraman, K Muthusamy
Plos one 13 (10), e0203194, 2018
132018
E-pharmacophore filtering and molecular dynamics simulation studies in the discovery of potent drug-like molecules for chronic kidney disease
S Nagamani, K Muthusamy, JJ Marshal
Journal of Biomolecular Structure and Dynamics 34 (10), 2233-2250, 2016
122016
Identification of novel small molecules that bind to the Loop2 region of sclerostin-an in silico computational analysis
K Muthusamy, S Mohan, S Nagamani, C Kesavan
Physiological Research 65 (5), 871, 2016
122016
Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach
SS Madugula, S Nagamani, E Jamir, L Priyadarsinee, GN Sastry
Molecular Diversity 26 (3), 1675-1695, 2022
112022
Exploring the Carbamazepine Interaction with Human Pregnane X Receptor and Effect on ABCC2 Using in Vitro and in Silico Approach
GK Grewal, KD Singh, N Kanojia, C Rawat, S Kukal, A Jajodia, A Singhal, ...
Pharmaceutical research 34, 1444-1458, 2017
112017
The binding mode prediction and similar ligand potency in the active site of vitamin D receptor with QM/MM interaction, MESP, and MD simulation
N Selvaraman, SK Selvam, K Muthusamy
Chemical biology & drug design 88 (2), 272-280, 2016
112016
系统目前无法执行此操作,请稍后再试。
文章 1–20